23andMe Suspends Health Interpretations | GenomeWeb

Direct-to-consumer genetic testing company 23andMe has stopped offering its health-related test to new customers, bringing it in line with a request from the US Food and Drug Administration.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

A lack of stability in research funding drives researchers away from academia, researchers write at eLife.

In PLOS this week: canine GWAS of skeletal syndromes, Chagas disease outcomes and genetic ancestry, and more.

A team describes its idea for a clinical trial data-sharing database, called Vivli, ScienceInsider reports.

One case illustrates how DNA evidence can incriminate an innocent person, Scientific American says.